“Promising Compound ZINC000032506419 Targets Fractalkine Receptor to Increase Insulin Production in Type 2 Diabetes Treatment”

https://pubmed.ncbi.nlm.nih.gov/38112285

Researchers have identified a promising drug-like compound, ZINC000032506419, that could potentially treat Type 2 diabetes by targeting the Fractalkine receptor and increasing insulin production.